EcoDrugPlus

Cyclin Dependent Kinase 7

Ensembl ID : ENSOKIG00005003846
Gene Symbol: CDK7
3 Cross references
216 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSOKIG00005038769
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cyclin-Dependent Kinase 1

Ensembl ID : ENSOKIG00005025794
Gene Symbol: LOC109899760
3 Cross references
241 Possible Orthologues:

Cyclin-Dependent Kinase 1-Like

Ensembl ID : ENSOKIG00005046533
Gene Symbol: LOC109890002
3 Cross references
241 Possible Orthologues:

Cyclin-Dependent Kinase 2

Ensembl ID : ENSOKIG00005030929
Gene Symbol: CDK2
1 Cross references
196 Possible Orthologues:

Cyclin-Dependent Kinase 4-Like

Ensembl ID : ENSOKIG00005003611
Gene Symbol: LOC109894658
3 Cross references
233 Possible Orthologues:

Cyclin-Dependent Kinase 6-Like

Ensembl ID : ENSOKIG00005013975
Gene Symbol: LOC109904398
3 Cross references
194 Possible Orthologues:

Cyclin-Dependent-Like Kinase 5

Ensembl ID : ENSOKIG00005045617
Gene Symbol: LOC109871937
3 Cross references
165 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSOKIG00005009200
Gene Symbol: CYSLTR1
3 Cross references
166 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1-Like

Ensembl ID : ENSOKIG00005029326
Gene Symbol: LOC109875302
3 Cross references
165 Possible Orthologues:

Cystic Fibrosis Transmembrane Conductance Regulator-Like

Ensembl ID : ENSOKIG00005015381
Gene Symbol: LOC109889621
3 Cross references
210 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSOKIG00005024360
Gene Symbol: LOC109908228
3 Cross references
151 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).